Literature DB >> 1729694

Generation of plasmacytomas with the chromosomal translocation t(12;15) in interleukin 6 transgenic mice.

S Suematsu1, T Matsusaka, T Matsuda, S Ohno, J Miyazaki, K Yamamura, T Hirano, T Kishimoto.   

Abstract

The mechanisms through which pristane or mineral oil can induce plasmacytomas in BALB/c or NZB mice are not fully understood, but involvement of interleukin 6 (IL-6), a growth factor for plasmacytomas and myelomas, has been strongly suggested. To clarify the role of IL-6 in plasmacytomagenesis, a human IL-6 cDNA was introduced into mouse germ lines under the transcriptional control of the murine major histocompatibility complex class I (H-2Ld) promoter. IL-6 transgenic mice of C57BL/6 origin developed a massive plasmacytosis but not plasmacytomas. However, introduction of BALB/c genetic background into IL-6 transgenic mice could generate monoclonal transplantable plasmacytomas with the chromosomal translocation t(12;15). These results provide firm evidence of the critical role of IL-6 in the plasmacytoma development.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1729694      PMCID: PMC48210          DOI: 10.1073/pnas.89.1.232

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  22 in total

1.  Overexpression of TGF alpha in transgenic mice: induction of epithelial hyperplasia, pancreatic metaplasia, and carcinoma of the breast.

Authors:  E P Sandgren; N C Luetteke; R D Palmiter; R L Brinster; D C Lee
Journal:  Cell       Date:  1990-06-15       Impact factor: 41.582

2.  Induction of plasma-cell neoplasms in strain BALB/c mice with mineral oil and mineral oil adjuvants.

Authors:  M POTTER; C R BOYCE
Journal:  Nature       Date:  1962-03-17       Impact factor: 49.962

Review 3.  Growth factors in development, transformation, and tumorigenesis.

Authors:  M Cross; T M Dexter
Journal:  Cell       Date:  1991-01-25       Impact factor: 41.582

4.  cDNA cloning of murine interleukin-HP1: homology with human interleukin 6.

Authors:  J Van Snick; S Cayphas; J P Szikora; J C Renauld; E Van Roost; T Boon; R J Simpson
Journal:  Eur J Immunol       Date:  1988-02       Impact factor: 5.532

5.  Activation of a translocated human c-myc gene by an enhancer in the immunoglobulin heavy-chain locus.

Authors:  A C Hayday; S D Gillies; H Saito; C Wood; K Wiman; W S Hayward; S Tonegawa
Journal:  Nature       Date:  1984 Jan 26-Feb 1       Impact factor: 49.962

Review 6.  Biological and clinical aspects of interleukin 6.

Authors:  T Hirano; S Akira; T Taga; T Kishimoto
Journal:  Immunol Today       Date:  1990-12

7.  Negative regulation of the major histocompatibility class I gene in undifferentiated embryonal carcinoma cells.

Authors:  J Miyazaki; E Appella; K Ozato
Journal:  Proc Natl Acad Sci U S A       Date:  1986-12       Impact factor: 11.205

8.  Nonrandom chromosome changes involving the Ig gene-carrying chromosomes 12 and 6 in pristane-induced mouse plasmacytomas.

Authors:  S Ohno; M Babonits; F Wiener; J Spira; G Klein; M Potter
Journal:  Cell       Date:  1979-12       Impact factor: 41.582

9.  An E mu-v-abl transgene elicits plasmacytomas in concert with an activated myc gene.

Authors:  H Rosenbaum; A W Harris; M L Bath; J McNeall; E Webb; J M Adams; S Cory
Journal:  EMBO J       Date:  1990-03       Impact factor: 11.598

10.  Chromosomal translocations activating myc sequences and transduction of v-abl are critical events in the rapid induction of plasmacytomas by pristane and abelson virus.

Authors:  S Ohno; S Migita; F Wiener; M Babonits; G Klein; J F Mushinski; M Potter
Journal:  J Exp Med       Date:  1984-06-01       Impact factor: 14.307

View more
  68 in total

1.  Genetic reporter system for oncogenic Igh-Myc translocations in mice.

Authors:  M Takizawa; J S Kim; L Tessarollo; N McNeil; T J Waldschmidt; R Casellas; T Ried; S Janz
Journal:  Oncogene       Date:  2010-05-10       Impact factor: 9.867

2.  SOCS3 deletion in B cells alters cytokine responses and germinal center output.

Authors:  Sarah A Jones; Christine A White; Lorraine Robb; Warren S Alexander; David M Tarlinton
Journal:  J Immunol       Date:  2011-11-09       Impact factor: 5.422

3.  The feed-forward loop between YB-1 and MYC is essential for multiple myeloma cell survival.

Authors:  K S Bommert; M Effenberger; E Leich; M Küspert; D Murphy; C Langer; R Moll; S Janz; A Mottok; S Weissbach; A Rosenwald; R Bargou; K Bommert
Journal:  Leukemia       Date:  2012-07-09       Impact factor: 11.528

4.  IL-6 transgenic mouse model for extraosseous plasmacytoma.

Authors:  Alexander L Kovalchuk; Joong Su Kim; Sung Sup Park; Allen E Coleman; Jerrold M Ward; Herbert C Morse; Tadamitsu Kishimoto; Michael Potter; Siegfried Janz
Journal:  Proc Natl Acad Sci U S A       Date:  2002-01-22       Impact factor: 11.205

Review 5.  Transgenic mice in the study of cytokine function.

Authors:  J Taverne
Journal:  Int J Exp Pathol       Date:  1993-12       Impact factor: 1.925

6.  Hypothesis. HHV-8 in multiple myeloma: is this the first paracrine model of human tumorigenesis and do Koch's postulates apply?

Authors:  J J O'Leary; I Silva; V Uhlmann; M Prasad; K Luttich; A Maffei; S Picton
Journal:  Mol Pathol       Date:  1998-08

7.  Molecular cloning of the complementary DNA and gene that encode mouse brain natriuretic peptide and generation of transgenic mice that overexpress the brain natriuretic peptide gene.

Authors:  Y Ogawa; H Itoh; N Tamura; S Suga; T Yoshimasa; M Uehira; S Matsuda; S Shiono; H Nishimoto; K Nakao
Journal:  J Clin Invest       Date:  1994-05       Impact factor: 14.808

8.  A human GM-CSF receptor expressed in transgenic mice stimulates proliferation and differentiation of hemopoietic progenitors to all lineages in response to human GM-CSF.

Authors:  I Nishijima; T Nakahata; Y Hirabayashi; T Inoue; H Kurata; A Miyajima; N Hayashi; Y Iwakura; K Arai; T Yokota
Journal:  Mol Biol Cell       Date:  1995-05       Impact factor: 4.138

9.  Quantitative tomography of early-onset spontaneous AA amyloidosis in interleukin 6 transgenic mice.

Authors:  Jonathan S Wall; Tina Richey; Amy Allen; Robert Donnell; Steve J Kennel; Alan Solomon
Journal:  Comp Med       Date:  2008-12       Impact factor: 0.982

10.  Hepatocellular hyperplasia, plasmacytoma formation, and extramedullary hematopoiesis in interleukin (IL)-6/soluble IL-6 receptor double-transgenic mice.

Authors:  P Schirmacher; M Peters; G Ciliberto; M Blessing; J Lotz; K H Meyer zum Büschenfelde; S Rose-John
Journal:  Am J Pathol       Date:  1998-08       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.